Skip to content
10-Q

Quarterly Report

BLACK DIAMOND THERAPEUTICS, INC. BDTX

0001701541-26-000017

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 1, 2026 57.3M sh
Shares Diluted Q1 2026 · Mar 31, 2026 57.23M sh
Shares Diluted Q1 2026 · Mar 31, 2025 57.67M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$10.23M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $53.41M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $30.07M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $20.99M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $98.42M
Stockholders Equity Q1 2026 · Mar 31, 2026 $104.3M
Stockholders Equity Q1 2026 · Dec 31, 2025 $112.21M
Stockholders Equity Q1 2026 · Mar 31, 2025 $141.52M
Stockholders Equity Q1 2026 · Dec 31, 2024 $83.29M
Current Liabilities Q1 2026 · Mar 31, 2026 $14.53M
Current Liabilities Q1 2026 · Dec 31, 2025 $15.73M
Total Liabilities Q1 2026 · Mar 31, 2026 $28.62M
Total Liabilities Q1 2026 · Dec 31, 2025 $30.8M
Current Assets Q1 2026 · Mar 31, 2026 $122.97M
Current Assets Q1 2026 · Dec 31, 2025 $132.44M
Total Assets Q1 2026 · Mar 31, 2026 $132.92M
Total Assets Q1 2026 · Dec 31, 2025 $143.01M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.16
Eps Diluted Q1 2026 · Mar 31, 2025 $0.98
Eps Basic Q1 2026 · Mar 31, 2026 −$0.16
Eps Basic Q1 2026 · Mar 31, 2025 $1.00
Sga Expense Q1 2026 · Mar 31, 2026 $4.26M
Sga Expense Q1 2026 · Mar 31, 2025 $4.96M
Rd Expense Q1 2026 · Mar 31, 2026 $7M
Rd Expense Q1 2026 · Mar 31, 2025 $10.51M
Net Income Q1 2026 · Mar 31, 2026 −$9.04M
Net Income Q1 2026 · Mar 31, 2025 $56.54M
Operating Income Q1 2026 · Mar 31, 2026 −$11.26M
Operating Income Q1 2026 · Mar 31, 2025 $54.53M